Resistance to Single-agent Chemotherapy for Low-risk Gestational Trophoblastic Neoplasia

• मुख्य लेखकों: Shahrzad Sheikhhasani (लेखक), Aghdas Abdolrazaghnejad (लेखक), Azam sadat Mousavi (लेखक), Setareh Akhavan (लेखक), Narges Zamani (लेखक), Elham Feizabad (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Babol University of Medical Sciences, 2023-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Methotrexate (MTX) and actinomycin D (ActD) have been used as first-line chemotherapy agents in the treatment of low-risk gestational trophoblastic neoplasia (GTN). Although low-risk GTN is considered a curable disease, its reported primary remission rates of 49 to 93% reflect the diffic...